Ambea AB (AMBEA.ST), a Swedish healthcare company, Tuesday announced its second-quarter results, with stable net earnings, while pre-tax earnings increased from last year backed by a 16% increase in sales. In the second quarter, net profit remained unchanged at 95 million Swedish kronor as compared to the prior year. However, earnings per share increased 3% to 1.13 kronor from 1.09 kronor a year ago. The profit before tax increased to 138 million kronor from 130 million kronor in the same quarter last year. The firm reported an increased adjusted EBITA amounting to 311 million kronor from 271 million kronor in the prior year. Meanwhile, adjusted EBITA margin dropped to 7.6 percent from 7.7 percent last year. Net sales grew to 4.088 billion kronor from 3.519 billion kronor in the same quarter last year. The company stated that the sales growth was largely due to the newly acquired Validia business area in Finland. Net sales of the newly acquired Nytida rose 10 per cent year-on-year to 1.15 billion kronor. In Stockholm, Ambea shares were trading 8% higher at 123.80 kronor.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.